rxstat › Shortages › Insulin Glulisine

Insulin Glulisine (Apidra) shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Aug 21, 2026

A shortage of Insulin Glulisine is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.

A rapid-acting insulin used to control blood sugar at mealtimes in diabetes.

Products affected
0 / 3
Reports on file
19

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Anticipated
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279479
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02294346 · ended Jul 30, 2026
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279479 · ended Jul 14, 2026
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02294346 · ended Jun 12, 2026
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279479 · ended May 29, 2026
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02294346 · ended Jan 30, 2026
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279479 · ended Jan 28, 2026
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279460 · ended Jul 11, 2023
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279479 · ended Jul 11, 2023
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02294346 · ended Jul 11, 2023
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279479 · ended Oct 11, 2022 · Demand increase for the drug.
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02294346 · ended Sep 23, 2022 · Delay in shipping of the drug.

Showing 12 of 19 reports. All reports are on file with Health Canada.

What's happening

A manufacturer has told Health Canada it expects supply of Insulin Glulisine to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Insulin Glulisine is classified under “INSULINS AND ANALOGUES” (ATC A10AB).

Recent changes

Common questions

What is Insulin Glulisine used for?

A rapid-acting insulin used to control blood sugar at mealtimes in diabetes.

When will Insulin Glulisine be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Insulin Glulisine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (insulins and analogues)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Insulin (Myxredlin) No current shortage Insulin Injection Human Biosynthetic (Novolin Ge Toronto Penfill) No current shortage Insulin Aspart (Fiasp) Partial shortage 1 of 8 reported products affected Insulin Glargine (Lantus) Partial shortage 1 of 6 reported products affected Insulin Lispro (Admelog) Partial shortage 1 of 5 reported products affected Insulin Detemir (Levemir Penfill) Discontinued 0 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.